Methimazole-induced severe febrile neutropenia responding to recombinant human granulocyte colony stimulating factor.
Fadi I
FI
Jabr
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000188:drug therapy; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008713:Methimazole / Q000009:adverse effects* / Q000627:therapeutic use; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D011994:Recombinant Proteins
D013956:Antithyroid Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole; D000069585:Filgrastim